Security Alert

Beware of fraudulent messages impersonating amana.

We have been made aware of fraudulent emails, messages, and job offers circulating online from individuals falsely claiming to represent amana.

These scams may promise investment opportunities, employment, or financial rewards while requesting personal information, payments, or account details.

Please note that the only official amana website is
www.amana.app

Please also be aware of the following fraudulent domains impersonating amana:

amanacapital961
amana.live
getamana.com
client.amana-trade.com
amanatrade.net
amana-capital.net
amaanahcapitall.com

logo

Deposit $200 to get a $100 trading bonus.

Use the promo code AMANAWEB.

Sign up now.*T&Cs Apply.

Terms & Conditions

  1. Offer valid for new users signing up on amana.
  2. How to Qualify for $100 Trading Bonus:
    • Sign up via the website.
    • Complete onboarding by providing the required details.
    • Enter promo code AMANAWEB at the final step.
    • Deposit $100 or more before your first trade.
    • Make your first trade.
  3. Once all steps are completed, you’ll receive a $100 non-withdrawable trading bonus.
  4. Bonuses are credited during the first week of every month.
  5. The bonus can only be used for trading and cannot be withdrawn.
  6. The campaign is exclusive to selected amana customers.
  7. amana reserves the right to cancel bonuses in cases of suspected fraud.
TRVI icon

TRVI

13.86 USD

-4.82%

Today

-1.52%

1D

Market is closed

Sun

Closed

Mon

4:30 PM ~ 10:59 PM

Tue

4:30 PM ~ 10:59 PM

Wed

4:30 PM ~ 10:59 PM

Thu

4:30 PM ~ 10:59 PM

Fri

4:30 PM ~ 10:59 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Trevi Therapeutics Inc.

Currency

USD

Market Cap

1.97B

Avg Daily Volume

1.96M

52 Week High

20.22 USD

52 Week Low

9.82 USD

Trading Hours

See hours

Business Summary

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company develops Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough in patients with IPF, and phase 2a clinical trial in patients with refractory chronic cough. Trevi Therapeutics, Inc. has a license agreement with Keenova Therapeutics plc to develop and commercialize products incorporating nalbuphine hydrochloride in various formulations. Trevi Therapeutics, Inc. was incorporated in 2011 and is headquartered in New Haven, Connecticut.

Top News

Trevi.Therapeutics

+7.29%

Trevi Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 9, 2026

tradingview.com

1d ago

No Image

Trevi.Therapeutics

+7.29%

Trevi Therapeutics (TRVI) Stock May Still Look Expensive Against Book Value

finance.yahoo.com

2d ago

No Image

Trevi.Therapeutics

+7.29%

Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference

tradingview.com

1w ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.

Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.

What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.

What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.